title: A novel function of prolactin-releasing peptide in the control of growth hormone via secretion of somatostatin from the hypothalamus.
abstract: The present study examined a novel function of PRL-releasing peptide (PrRP) on the neuroendocrine. PrRP-immunoreactive nerve fibers and nerve terminals were located in the vicinity of the somatostatin (SOM)-neurons in the hypothalamic periventricular nucleus (PerVN). Immuno-electron microscopy revealed that PrRP-immunoreactive nerve terminals made synaptic contacts with nonimmunoreactive neuronal elements in the PerVN. Intracerebroventricular (icv) administration of PrRP induced immediate early gene, NGFI-A, in SOM-neurons in the PerVN. Double-labeling in situ hybridization showed that some parts of SOM-neurons in the PerVN expressed PrRP receptor messenger RNA. Therefore, some parts of SOM-neurons in the PerVN are considered to be directly innervated by PrRP via PrRP receptor. In addition to the above morphological characteristics, icv administration of PrRP decreased plasma GH levels. Such inhibitory effects of PrRP on the secretion of GH from the anterior pituitary were diminished by depletion or neutralization of SOM. From these findings it was strongly suggested that SOM-neurons respond to PrRP and secrete SOM into the portal vessels and thus inhibit GH secretion from the anterior pituitary.
authors: Department of Anatomy, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan.
authors: N
authors: N
authors: Iijima
authors: Y
authors: Y
authors: Matsumoto
authors: T
authors: T
authors: Yano
authors: M
authors: M
authors: Tanaka
authors: T
authors: T
authors: Yamamoto
authors: K
authors: K
authors: Kakihara
authors: Y
authors: Y
authors: Kataoka
authors: Y
authors: Y
authors: Tamada
authors: H
authors: H
authors: Matsumoto
authors: N
authors: N
authors: Suzuki
authors: S
authors: S
authors: Hinuma
authors: Y
authors: Y
authors: Ibata
mesh_terms: D000818:Animals; D003543:Cysteamine / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D007028:Hypothalamic Hormones / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism*; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D008297:Male; D009411:Nerve Endings / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D009479:Neuropeptides / Q000494:pharmacology; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D056690:Prolactin-Releasing Hormone; D051381:Rats; D017208:Rats, Wistar; D018013:Receptors, Neuropeptide / Q000502:physiology; D013004:Somatostatin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*
chemical_list: D007028:Hypothalamic Hormones; D009479:Neuropeptides; C534379:Prlh protein, rat; D056690:Prolactin-Releasing Hormone; D018013:Receptors, Neuropeptide; C400801:receptor, prolactin-releasing peptide; D013004:Somatostatin; D003543:Cysteamine; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone